“The Pharma sector is expected to remain range-bound in the short term, having been in a broad consolidation for the past year. Despite a recent rally, the index failed to sustain gains, indicating a lack of clear directional momentum.”

Rupak De’s track record: 27 graded calls · 95% CI 34–69%